MedPath

Zanosar

ZANOSAR (Streptozocin Sterile Powder)

Approved
Approval ID

15d161ed-9e7b-4c92-ba45-0556d2423e67

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Apr 24, 2023

Manufacturers
FDA

Teva Parenteral Medicines, Inc.

DUNS: 794362533

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

streptozocin

PRODUCT DETAILS

NDC Product Code0703-4636
Application NumberNDA050577
Marketing CategoryC73594
Route of AdministrationINTRAVENOUS
Effective DateJune 29, 2023
Generic Namestreptozocin

INGREDIENTS (3)

STREPTOZOCINActive
Quantity: 100 mg in 1 mL
Code: 5W494URQ81
Classification: ACTIB
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
ANHYDROUS CITRIC ACIDInactive
Code: XF417D3PSL
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Zanosar - FDA Drug Approval Details